Avalo Therapeutics Inc. buy Lokrim
Start price
21.07.25
/
20%
€5.65
Target price
21.07.26
-
Performance (%)
112.74%
Price
06.02.26
€10.92
Summary
This prediction is currently active. The BUY prediction by Lokrim for Avalo Therapeutics Inc. has seen massive gains of 112.74%. This prediction currently runs until 21.07.26. The prediction end date can be changed by Lokrim at any time. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Avalo Therapeutics Inc. | - | - |
| iShares Core DAX® | 0,46 % | -2,00 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % |
| iShares S&P 500 | -1,76 % | -3,67 % |
According to Lokrim what are the pros and cons of Avalo Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Cons
Revenue decline/stagnation expected
Comments by Lokrim for this prediction
In the thread Avalo Therapeutics Inc. diskutieren
Stopped prediction by Lokrim for Avalo Therapeutics Inc.
Avalo Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.52
04.08.24
04.08.24
-
04.08.25
04.08.25
-40.65%
21.07.25
21.07.25
Could be worthwhile Investment >10% per year
Capable Management
Revenue decline/stagnation expected
